261 related articles for article (PubMed ID: 7923979)
1. Long-term experience with high-flux polysulfone in hemodialysis.
Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
[No Abstract] [Full Text] [Related]
2. Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer.
Schaefer RM; Kulzer P; Gilge U; Schaefer L; Heidland A
Clin Nephrol; 1994 Jul; 42 Suppl 1():S21-5. PubMed ID: 7923978
[No Abstract] [Full Text] [Related]
3. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
[No Abstract] [Full Text] [Related]
4. Clinical experience with polysulfone: 10 years.
Vanholder R; Van Loo A; Ringoir S
Clin Nephrol; 1994 Jul; 42 Suppl 1():S13-20. PubMed ID: 7923977
[No Abstract] [Full Text] [Related]
5. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
6. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
Lonnemann G; Schindler R
Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
[No Abstract] [Full Text] [Related]
7. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
8. Phosphate removal during dialysis--does the membrane matter?
Ritz E
Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
[No Abstract] [Full Text] [Related]
9. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
Starzyk J; Bartelik S; Sarnecka S
Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
[TBL] [Abstract][Full Text] [Related]
10. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
Kadiri S; Kehinde Z; Arije A; Salako BL
Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
[TBL] [Abstract][Full Text] [Related]
11. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
Ljungberg B; Jacobson SH; Lins LE; Pejler G
Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
[TBL] [Abstract][Full Text] [Related]
12. All high-flux membranes are equal but some high-flux membranes are less equal than others.
Vanholder R; Pedrini LA
Nephrol Dial Transplant; 2008 May; 23(5):1481-3. PubMed ID: 18305315
[No Abstract] [Full Text] [Related]
13. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
[TBL] [Abstract][Full Text] [Related]
14. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
15. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
[No Abstract] [Full Text] [Related]
16. Hemodialysis using high flux membranes improves lipid profiles.
Blankestijn PJ
Clin Nephrol; 1994 Jul; 42 Suppl 1():S48-51. PubMed ID: 7923984
[No Abstract] [Full Text] [Related]
17. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
18. Fresenius Polysulfone--the "gold standard" in dialysis. 10 Years of experience.
Brachtendorf T; Nederlof B
Clin Nephrol; 1994 Jul; 42 Suppl 1():S3-12. PubMed ID: 7923980
[No Abstract] [Full Text] [Related]
19. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
[TBL] [Abstract][Full Text] [Related]
20. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
